Alkermes plc. (ALKS) bonds
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30213% above fair value
$46.98−0.91 (-1.90%)
Close on Nov 12, 2026Market cap $7.88BP/E 123.6Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$1.50B
$26.50M due within a year
Net debt
$991.58M
After $511.53M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
20.7×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in Alkermes's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Matures | Carrying value |
|---|---|---|---|
| Term Loan A Facility, due February 12, 2031 | – | Feb 12, 2031 | $739.40M |
| Term Loan B Facility, due August 12, 2031 | – | Aug 12, 2031 | $763.71M |
| Former Term Loans | Floating + 2.50% | – | $290.73M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?